D. Western Therapeutics Institute, Inc. (FRA:6DW)
Germany flag Germany · Delayed Price · Currency is EUR
0.5400
+0.0200 (3.85%)
At close: Nov 28, 2025

FRA:6DW Statistics

Total Valuation

FRA:6DW has a market cap or net worth of EUR 31.50 million. The enterprise value is 25.20 million.

Market Cap31.50M
Enterprise Value 25.20M

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date Feb 9, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 53.14M
Shares Outstanding n/a
Shares Change (YoY) +33.08%
Shares Change (QoQ) +5.47%
Owned by Insiders (%) 12.73%
Owned by Institutions (%) -1.68%
Float 45.57M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 13.03
PB Ratio 3.73
P/TBV Ratio 3.77
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.14
EV / Sales 10.83
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.15, with a Debt / Equity ratio of 0.35.

Current Ratio 9.15
Quick Ratio 8.16
Debt / Equity 0.35
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -134.31

Financial Efficiency

Return on equity (ROE) is -85.00% and return on invested capital (ROIC) is -32.01%.

Return on Equity (ROE) -85.00%
Return on Assets (ROA) -29.73%
Return on Invested Capital (ROIC) -32.01%
Return on Capital Employed (ROCE) -53.09%
Revenue Per Employee 115,120
Profits Per Employee -289,558
Employee Count21
Asset Turnover 0.19
Inventory Turnover 0.42

Taxes

In the past 12 months, FRA:6DW has paid 9,186 in taxes.

Income Tax 9,186
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +13.45% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change +13.45%
50-Day Moving Average 0.56
200-Day Moving Average 0.59
Relative Strength Index (RSI) 54.51
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:6DW had revenue of EUR 2.42 million and -6.08 million in losses. Loss per share was -0.14.

Revenue2.42M
Gross Profit 2.17M
Operating Income -5.99M
Pretax Income -6.07M
Net Income -6.08M
EBITDA -5.70M
EBIT -5.99M
Loss Per Share -0.14
Full Income Statement

Balance Sheet

The company has 9.53 million in cash and 2.97 million in debt, giving a net cash position of 6.55 million.

Cash & Cash Equivalents 9.53M
Total Debt 2.97M
Net Cash 6.55M
Net Cash Per Share n/a
Equity (Book Value) 8.44M
Book Value Per Share 0.16
Working Capital 10.35M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 89.75%, with operating and profit margins of -247.66% and -251.53%.

Gross Margin 89.75%
Operating Margin -247.66%
Pretax Margin -251.15%
Profit Margin -251.53%
EBITDA Margin -235.80%
EBIT Margin -247.66%
FCF Margin n/a

Dividends & Yields

FRA:6DW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -33.08%
Shareholder Yield -33.08%
Earnings Yield -19.30%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:6DW has an Altman Z-Score of 3.48 and a Piotroski F-Score of 2.

Altman Z-Score 3.48
Piotroski F-Score 2